Tissue Engineered Cartilage to Repairing Articular Cartilage Defects
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe First Affiliated Hospital of Xinxiang Medical College
About this trial
The joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.
Eligibility criteria
Qualifiers
The patients' age ranges from 18 to 65 years old, and gender is not restricted;
The imaging results show that the epiphyseal growth is mature;
The defects or localized injuries of joint cartilage caused by trauma or other reasons;
The injured area is the distal weight-bearing surface of the femoral condyle of the knee joint, with no more than 4 lesions, and there is no injury to the cruciate ligaments;
Disqualifiers
The patient is extremely overweight, with a body mass index greater than 35;
The lower limb alignment is valgus by more than 10° and varus by more than 5°;
Multiple ligament injuries;
There are numerous bad habits such as heavy smoking, drug abuse, and excessive alcohol consumption;
Trial design
Treatments tested in this trial
- Tissue engineered cartilage
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov